Your browser doesn't support javascript.
loading
Fucoidan induces G1 arrest of the cell cycle in EJ human bladder cancer cells through down-regulation of pRB phosphorylation
Park, Hye Young; Choi, Il-Whan; Kim, Gi-Young; Kim, Byung Woo; Kim, Wun-Jae; Choi, Yung Hyun.
  • Park, Hye Young; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
  • Choi, Il-Whan; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
  • Kim, Gi-Young; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
  • Kim, Byung Woo; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
  • Kim, Wun-Jae; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
  • Choi, Yung Hyun; Dongeui University College of Korean Medicine. Department of Biochemistry. Busan. KR
Rev. bras. farmacogn ; 25(3): 246-251, May-June 2015. tab, ilus
Artigo em Inglês | LILACS | ID: lil-757435
ABSTRACT
AbstractFucoidan, a sulfated polysaccharide found in marine algae and brown seaweeds, has been shown to inhibit the in vitro growth of human cancer cells. This study was conducted in cultured human bladder cancer EJ cells to elucidate the possible mechanisms by which fucoidan exerts its anti-proliferative activity, which until now has remained poorly understood. Fucoidan treatment of EJ cells resulted in dose-dependent inhibition of cell growth and induced apoptotic cell death. Flow cytometric analysis revealed that fucoidan led to G1 arrest in cell cycle progression. It was associated with down-regulation of cyclin D1, cyclin E, and cyclin-dependent-kinases (Cdks) in a concentration-dependent manner, without any change in Cdk inhibitors, such as p21 and p27. Furthermore, dephosphorylation of retinoblastoma protein (pRB) by this compound was associated with enhanced binding of pRB with the transcription factors E2F-1 and E2F-4. Overall, our results demonstrate that fucoidan possesses anticancer activity potential against bladder cancer cells by inhibiting pRB phosphorylation.


Texto completo: DisponíveL Índice: LILACS (Américas) Idioma: Inglês Revista: Rev. bras. farmacogn Assunto da revista: Farmácia Ano de publicação: 2015 Tipo de documento: Artigo / Documento de projeto País de afiliação: Coréia do Sul Instituição/País de afiliação: Dongeui University College of Korean Medicine/KR

Similares

MEDLINE

...
LILACS

LIS


Texto completo: DisponíveL Índice: LILACS (Américas) Idioma: Inglês Revista: Rev. bras. farmacogn Assunto da revista: Farmácia Ano de publicação: 2015 Tipo de documento: Artigo / Documento de projeto País de afiliação: Coréia do Sul Instituição/País de afiliação: Dongeui University College of Korean Medicine/KR